指南与共识骨软组织肉瘤与黑色素瘤支持与姑息治疗

胚系BAP1阳性患者的癌症监测困境与跨学科共识监测策略建议

Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
指南 / 共识 · Eur J Cancer · 2018-02-03

胚系BAP1突变相关癌症易感综合征自2011年首次描述,患者个人或家族史常表现为葡萄膜/皮肤黑色素瘤、胸膜/腹膜间皮瘤、肾细胞癌及BAP1缺陷性黑色素细胞病变。该突变阳性后癌症监测方案存在显著不确定性,多个团队提出监测计划但关键管理困境未解,终身患癌风险未知,监测能否早期发现癌症或改变生存结局亦不明确。本文在澳大利亚黑色素瘤研究所多学科团队会议上初步提出共识监测策略,并与癌症遗传学、病理学、放射学、肿瘤内科、眼科及皮肤科专家讨论,目标为促进早期诊断,尽可能采用基于临床的低/非电离辐射成像模式,应用良好筛查试验原则并聚焦多学科。

要点

  • 胚系BAP1阳性患者癌症监测方案缺乏共识,终身患癌风险未知。
  • 监测能否实现早期诊断或改善生存结局尚不明确。
  • 建议采用低/非电离辐射成像模式并遵循良好筛查试验原则。

核心结论

  • 胚系BAP1阳性患者的癌症监测存在重要管理困境,需跨学科共识策略以促进早期诊断。

研究设计与样本

  • 共识监测策略最初在澳大利亚黑色素瘤研究所黑色素瘤多学科团队会议上提出,后与癌症遗传学、病理学、放射学、肿瘤内科、眼科及皮肤科专家讨论。

主要发现

  • 胚系BAP1突变相关癌症易感综合征于2011年首次描述,典型肿瘤包括葡萄膜和皮肤黑色素瘤、胸膜/腹膜间皮瘤、肾细胞癌及BAP1缺陷性黑色素细胞病变。
  • 终身患癌风险未知,监测能否早期发现癌症或改变生存结局尚不明确。

关键数值与推荐

  • 共识监测策略目标为促进早期诊断,尽可能采用基于临床的低/非电离辐射成像模式,应用良好筛查试验原则并聚焦多学科。

临床怎么用

  • 对胚系BAP1阳性患者,可考虑多学科参与的监测策略,优先选择低/非电离辐射成像模式。

局限性

  • 终身患癌风险未知,监测对早期诊断和生存结局的影响尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The germline BAP1 (BRCA1-associated protein-1) mutation and associated cancer pre-disposition syndrome was first described in 2011. Since then, physicians have considered this diagnosis for patients with a characteristic personal or family history of BAP1-associated tumours (mainly uveal and cutaneous melanoma, pleural/peritoneal mesothelioma, renal cell carcinoma and BAP1-deficient melanocytic lesions). However, a positive germline BAP1 mutation detection creates significant uncertainty in terms of appropriate cancer surveillance. A number of groups have proposed surveillance plans but important management dilemmas remain unresolved. The lifetime risk of developing cancer is not known and it is not clear if surveillance would lead to detecting cancer at an earlier stage or change survival outcomes. A consensus monitoring strategy was initially proposed at the Melanoma Institute Australia Melanoma Multidisciplinary Team meeting and later discussed with specialists in the field of cancer genetics, pathology, radiology, medical oncology, ophthalmology and dermatology. The objectives were to facilitate early diagnosis, incorporating where possible, clinically based and low/non-ionising radiation imaging modalities, applying the principles of a good screening test and a multidisciplinary focus.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Star P, Goodwin A, Kapoor R, et al. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy. Eur J Cancer. 2018. PMID: 29413689. doi:10.1016/j.ejca.2017.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。